GPC2 and prostate carcinoma: A ceRNA network analysis of prostate cancer established a network consisting of four hub genes, homeobox B5 (HOXB5), glypican 2 (GPC2), pepsinogen A-5 (PGA5), and ameloblastin (AMBN), which are strongly associated with patient survival [9].